Ecomax Valuation
Is EMAX undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EMAX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EMAX ($0.18) is trading below our estimate of fair value ($0.99)
Significantly Below Fair Value: EMAX is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EMAX?
Other financial metrics that can be useful for relative valuation.
What is EMAX's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$419.05k |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1x |
Enterprise Value/EBITDA | n/a |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does EMAX's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.9x | ||
AIXN AiXin Life International | 3.1x | n/a | US$13.8m |
GNLN Greenlane Holdings | 0.09x | n/a | US$2.7m |
CTNT Cheetah Net Supply Chain Service | 0.5x | -37.5% | US$7.9m |
MSSV Regenerative Medical Technology Group | 0.1x | n/a | US$337.3k |
EMAX Ecomax | 0.5x | n/a | US$419.0k |
Price-To-Sales vs Peers: EMAX is good value based on its Price-To-Sales Ratio (0.5x) compared to the peer average (12.1x).
Price to Earnings Ratio vs Industry
How does EMAX's PE Ratio compare vs other companies in the US Retail Distributors Industry?
Price-To-Sales vs Industry: EMAX is good value based on its Price-To-Sales Ratio (0.5x) compared to the Global Retail Distributors industry average (0.8x).
Price to Sales Ratio vs Fair Ratio
What is EMAX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.5x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate EMAX's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.